Jacobs Levy Equity Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $738K | Sell |
63,369
-53,700
| -46% | -$626K | ﹤0.01% | 815 |
|
|
2025
Q1 | $870K | Sell |
117,069
-33,002
| -22% | -$245K | ﹤0.01% | 833 |
|
|
2024
Q4 | $900K | Buy |
150,071
+6,392
| +4% | +$38.3K | ﹤0.01% | 729 |
|
|
2024
Q3 | $736K | Buy |
+143,679
| New | +$736K | ﹤0.01% | 778 |
|
|
2024
Q1 | – | Sell |
-428,858
| Closed | -$2.1M | – | 934 |
|
|
2023
Q4 | $2.1M | Buy |
+428,858
| New | +$2.1M | 0.01% | 593 |
|
|
2023
Q3 | – | Sell |
-50,930
| Closed | -$342K | – | 953 |
|
|
2023
Q2 | $342K | Sell |
50,930
-6,184
| -11% | -$41.5K | ﹤0.01% | 860 |
|
|
2023
Q1 | $504K | Sell |
57,114
-23,749
| -29% | -$210K | ﹤0.01% | 801 |
|
|
2022
Q4 | $618K | Sell |
80,863
-34,963
| -30% | -$267K | ﹤0.01% | 753 |
|
|
2022
Q3 | $825K | Buy |
+115,826
| New | +$825K | 0.01% | 743 |
|
|
2021
Q3 | – | Sell |
-14,773
| Closed | -$604K | – | 1022 |
|
|
2021
Q2 | $604K | Buy |
14,773
+4,435
| +43% | +$181K | ﹤0.01% | 829 |
|
|
2021
Q1 | $416K | Sell |
10,338
-30,227
| -75% | -$1.22M | ﹤0.01% | 887 |
|
|
2020
Q4 | $2.4M | Sell |
40,565
-897
| -2% | -$53K | 0.02% | 540 |
|
|
2020
Q3 | $2.02M | Buy |
41,462
+15,764
| +61% | +$766K | 0.02% | 519 |
|
|
2020
Q2 | $1.24M | Buy |
+25,698
| New | +$1.24M | 0.01% | 628 |
|